Privi Speciality Chemicals (PRIVISCL) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
15 Apr, 2026Executive summary
Delivered robust performance in Q3 and nine months FY26, achieving 24% year-over-year revenue growth driven by diversified product mix, operational efficiencies, and resilience amid global trade uncertainties and geopolitical headwinds.
Strategic three-phase expansion roadmap and focus on innovation, sustainability, and capacity expansion to increase capacity by 55% and broaden specialty product portfolio over the next 2-3 years.
Amalgamation of subsidiaries underway to unlock synergies and enhance operational efficiency.
Strengthening trade ties with the US and EU, and favorable tariff changes, position the company for export-led growth.
Unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025, were reviewed and approved on February 9, 2026, with statutory auditors expressing an unmodified review conclusion.
Financial highlights
Q3 FY26 consolidated revenue grew 24% year-over-year to INR 611.15 crore (₹60,464.10 lakhs); nine-month revenue at INR 1,857 crore, also up 24%.
Q3 EBITDA rose 37% year-over-year to INR 158 crore, with a margin of 25.83%; Q3 PAT at INR 82 crore (up 76% YoY); nine-month PAT at INR 233.84 crore, up 94% year-over-year.
Nine-month EBITDA at INR 481 crore, up 47% year-over-year, with a margin of 25.9%.
Basic and diluted EPS (consolidated) for Q3 FY26 was ₹19.97, up from ₹11.38 in Q3 FY25; nine-month EPS at ₹59.86, up from ₹30.84.
One-time expense of Rs. 389.96 lakh due to new labor legislation in Nov 2025.
Outlook and guidance
Targeting INR 5,000 crore revenue and INR 1,000 crore EBITDA within 3-4 years, with EBITDA margin guidance above 20% and management aiming to sustain 22-25% margins.
Volume growth expected at 7-15% in the coming year, with value growth likely to outpace volume due to value-added products.
Capacity utilization expected to remain around 90% as new capacity comes online.
Continued investments in green chemistry, biotechnology, and digital transformation.
The company continues to monitor the impact of new labour codes and will recognize adjustments as needed when further clarifications are issued.
Latest events from Privi Speciality Chemicals
- Q3 and 9M FY25 saw robust revenue and profit growth, with strong outlook and export momentum.PRIVISCL
Q3 24/2523 Dec 2025 - Strong double-digit growth, margin expansion, and clear path to INR 5,000 crore revenue.PRIVISCL
Q1 25/2623 Nov 2025 - FY25 saw record profit and revenue growth, robust margins, and a Rs. 5 dividend recommended.PRIVISCL
Q4 24/2518 Nov 2025 - Record growth, margin expansion, and sustainability awards drive a strong multi-year outlook.PRIVISCL
Q2 25/267 Nov 2025 - Record revenue, margin expansion, and a new JV facility highlight strong quarterly growth.PRIVISCL
Q2 24/2513 Jun 2025 - Strong profit and revenue growth, with new JV and solar project fueling future momentum.PRIVISCL
Q1 24/2513 Jun 2025